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1. Introduction 
The bolus intravenous injection of a novel medium-chain triglyceride:fish oil emulsion was 
recently proposed as a suitable tool to increase within 60 min the long-chain 
polyunsaturated ω3 fatty acid content of cell phospholipids (Carpentier et al., 2010). The 
optimal procedure for the dietary correction of the metabolic and hormonal perturbations 
found in situations of ω3-depletion, in terms of the total lipid content and source of ω3 fatty 
acids in the diet, as well as the time course for the enrichment of tissue lipids in these ω3 
fatty acids, merits, however, further attention (Malaisse et al., 2011). In such a perspective, 
the present report deals mainly with the possible suitability of a diet containing 5% (w/w) 
soya oil, as assessed in rats first exposed for 3 months to an ω3-deficient sunflower oil (also 
5%) diet. 
2. Materials and methods 
Six groups of 4 fed female rats each were examined in the present study. Two groups 
consisted of control animals exposed from the age of 8 weeks after birth for 3 months to a 
diet containing 5% (w/w) soya oil and examined either at the end of this 3 months initial 
period or 8 weeks later whilst being maintained on the soya oil diet. The other 4 groups of 
rats were first exposed during the initial 3 months period to a diet containing 5% (w/w) 
sunflower oil (ω3D rats) and examined either at the end of this 3 months initial period or 
after further exposure for one, two or eight weeks to the soya oil diet. Six further ω3D rats 
were maintained after the end of the initial 3 months period and for the ensuing 8 weeks to 
the sunflower oil diet, but were only examined for their food intake and body weight. The 
rats were eventually sacrificed by CO2 inhalation. The methods used for collection of 
intestinal mucosa at the jejunal and caecal level (Hacquebard et al., 2009), liver (Malaisse et 
al., 2009), red blood cell (Carpentier et al., 2011a), brain (Portois et al., 2009) and both 
visceral and parametrial adipose tissue (Portois et al., 2007) sampling, lipid extraction (Folch 
et al., 1957), separation by thin-layer chromatography (Dahlan et al., 1992) and 
determination of lipid fatty acid pattern by gas-liquid chromatography (Lepage & Roy, 
1986), food intake measurements (Zhang et al., 2010) and plasma D-glucose (Lowry & 
Passonneau, 1972) and insulin (Leclercq-Meyer et al., 1985) determinations were previously 
described in the cited references. 
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All results are presented as mean values (± SEM) together with the number of individual 
observations (n) or degree of freedom (df). Except if otherwise mentioned, all tabulated 
values refer to four individual determinations. In the case of RBC, however, the 
measurements listed for ω3D rats examined 1 or 2 weeks after the switch in diet refer to 
single measurements made in pooled material from 4 rats. In the Tables, the indication N.T. 
refers to non-tabulated data. The statistical significance of differences between mean values 
was assessed by use of Student’s t-test. 
3. Results 
3.1 Fatty acid pattern of intestinal phospholipids 
3.1.1 Long-chain polyunsaturated ω3 fatty acids 
At the end of the 3 months initial period, the relative weight content of all ω3  fatty acids 
(C18:3ω3, C20:5ω3, C22:5ω3 and C22:6ω3) was significantly lower (p < 0.005 or less), 
whether in the jejunum or caecum, in the ω3D rats than in the control animals (Table 1). 
When the former rats were then exposed for one week to the soya oil diet, a significant 
increase (p < 0.02 or less) in the C18:3ω3, C22:5ω3 and C22:6ω3 relative content of jejunal 
phospholipids and in the C22:5ω3 and C22:6ω3 content of caecal phospholipids was 
observed, whilst such was not the case for either the C20:5ω3 content of jejunal 
phospholipids or C18:3ω3 and C20:5ω3 content of caecal phospholipids. Nevertheless, the 
mean values reached in the ω3D rats exposed for one week to the soya oil remained, as a 
rule, lower than those found in the control animals at the end of the 3 months initial period. 
Even, in the two out of eight instances in which such was not the case, i.e. for the C18:3ω3 
content of jejunal phospholipids and C22:5ω3 content of caecal phospholipids, no significant 
difference (p > 0.3 or more) was found between the two groups of rats under consideration. 
 
Rats C18:3ω3 C20:5ω3 C22:5ω3 C22:6ω3 
Jejunum 
Control before 7.10 ± 1.46 0.00 ± 0.00 4.18 ± 0.39 39.51 ± 2.00 
ω3D before 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 14.86 ± 1.62 
 after (1 wk) 8.30 ± 1.35 0.42 ± 0.42 2.89 ± 0.32 25.88 ± 2.18 
Caecum 
Control before 1.46 ± 1.46 2.76 ± 1.60 2.74 ± 2.74 49.94 ± 6.83 
ω3D before 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 5.49 ± 5.49 
 after (1 wk) 0.00 ± 0.00 0.00 ± 0.00 5.60 ± 0.65 23.80 ± 1.57 
Table 1. Relative weight content (‰) of long-chain polyunsaturated ω3 fatty acids in 
jejunum and caecum phospholipids 
3.1.2 Long-chain polyunsaturated ω6 fatty acids 
As shown in Table 2, no significant difference between the three groups of rats was 
observed in terms of the relative weight content of C18:2ω6, C20:3ω6 and C20:4ω6 in the 
jejunal phospholipids. However, the content of C20:2ω6, C22:4ω6 and C22:5ω6, expressed 
relative to their respective overall mean values averaged 38.2 ± 12.0% (n = 12) in the control 
animals examined at the end of the 3 months initial period, as distinct (p < 0.001) from 166.2 
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± 17.6% (n = 12) in the ω3D rats examined before the switch in diet. After one week exposure 
to the soya oil diet, the latter percentage was decreased (p < 0.005) to 95.6 ± 8.4% (n = 12), 
the latter value remaining higher (p < 0.001) than that recorded in the control animals. 
The relative weight content of ω6 fatty acids differed, on occasion, in the jejunal versus caecal 
phospholipids. For instance, the weight content of C18:2ω6 averaged 320.88 ± 9.60‰ (n = 12) 
at the jejunal level, as distinct (p < 0.001) from only 187.42 ± 5.53‰ (n = 12) at the caecal 
level. Moreover, as a rule, no significant difference between the mean values recorded in the 
three groups of rats was observed for the relative weight content of ω6 fatty acids in the 
caecal phospholipids. Only in the case of C22:5ω6, a significant increase (p < 0.001) in the 
content of this fatty acid in caecal phospholipids was found when comparing control 
animals and ω3D rats both examined at the end of the 3 months initial period, with an in-
between value (p < 0.01 or less) in the ω3D rats examined one week after the switch in diet. 
 
Rats C18:2ω6 C20:2ω6 C20:3ω6 C20:4ω6 C22:4ω6 C22:5ω6 
Jejunum 
Control before 314.40 ± 19.28 1.16 ± 0.68 5.71 ± 0.45 175.68 ± 21.41 4.24 ± 0.60 0.00 ± 0.00 
ω3D before 316.85 ± 16.43 4.61 ± 0.71 6.31 ± 0.75 173.77 ± 8.19 7.94 ± 1.66 16.80 ± 3.09 
 after (1 wk) 331.38 ± 17.79 2.87 ± 0.41 4.94 ± 0.58 167.09 ± 11.11 4.94 ± 0.39 8.48 ± 1.84 
Caecum 
Control before 192.02 ± 12.80 3.40 ± 1.96 16.50 ± 0.36 164.85 ± 12.04 16.69 ± 5.70 2.13 ± 1.32 
ω3D before 189.76 ± 8.28 0.00 ± 0.00 7.42 ± 4.34 200.00 ± 13.13 29.56 ± 3.28 26.47 ± 1.37 
 after (1 wk) 180.50 ± 8.92 3.66 ± 2.12 16.59 ± 0.62 214.29 ± 10.21 24.39 ± 1.05 16.12 ± 2.25 
Table 2. Relative weight content (‰) of long-chain polyunsaturated ω6 fatty acids in 
jejunum and caecum phospholipids 
3.1.3 Saturated fatty acids 
The relative weight content of saturated fatty acids often differed significantly in jejunal 
versus caecal phospholipids (Table 3). For instance, the C14:0 content was close to 15-fold 
higher (p < 0.001) in the caecal phospholipids (9.44 ± 1.13‰; n = 12) than in the jejunal 
phospholipids (0.64 ± 0.23‰; n = 12). Whether at the jejunal or caecal level, no significant 
difference was observed between the relative weight content of a given saturated fatty acid 
in the three groups of rats under consideration. 
 
Rats C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 
Jejunum 
Control before 0.00 ± 0.00 167.22 ± 3.42 198.25 ± 9.42 7.00 ± 0.79 7.58 ± 0.53 6.25 ± 0.51 
ω3D before 0.78 ± 0.45 164.31 ± 10.29 204.77 ± 5.02 9.32 ± 3.02 10.83 ± 2.73 9.24 ± 2.38 
 after (1 wk) 1.15 ± 0.39 160.78 ± 4.72 198.89 ± 6.32 7.30 ± 0.60 8.33 ± 0.69 8.43 ± 0.99 
Caecum 
Control before 7.79 ± 3.03 247.74 ± 15.67 123.27 ± 10.61 15.05 ± 3.28 18.09 ± 5.06 18.20 ± 7.70 
ω3D before 9.01 ± 0.69 242.60 ± 10.81 129.05 ± 4.07 11.83 ± 2.12 12.85 ± 2.12 9.61 ± 1.39 
 after (1 wk) 11.51 ± 1.38 233.53 ± 12.15 120.62 ± 4.78 10.55 ± 1.18 10.11 ± 1.24 7.98 ± 1.50 
Table 3. Relative weight content (‰) of saturated fatty acids in jejunum and caecum 
phospholipids 
3.1.4 Monodesaturated fatty acids 
The C16:1ω7 and C18:1ω9 relative weight content of jejunal phospholipids averaged, 
respectively, 2.97 ± 0.39‰ and 60.66 ± 2.82‰ (n = 12 in both cases), as distinct (p < 0.001) 
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from 10.01 ± 1.56‰ and 117.51 ± 2.01‰ (n = 12 in both cases) in caecal phospholipids. Such 
contents failed to differ significantly from one another, whether in the jejunum or caecum, in 
the three groups of rats under consideration (Table 4). A sizeable amount of C20:1ω9 in 
intestinal phospholipids was only detected in one out of 4 rats in the ω3D rats examined 
before or after the switch in diet. No C22:1ω9 could be detected in any of the 24 rats 
examined for such a purpose. 
 
Rats C16:1ω7 C18:1ω9 C20:1ω9 C22:1ω9 
Jejunum 
Control before 3.70 ± 0.70 58.03 ± 2.03 0.00 ± 0.00 0.00 ± 0.00 
ω3D before 2.50 ± 0.92 64.77 ± 2.11 0.43 ± 0.43 0.00 ± 0.00 
 after (1 wk) 2.71 ± 0.20 59.18 ± 3.94 0.05 ± 0.05 0.00 ± 0.00 
Caecum 
Control before 5.54 ± 3.34 120.28 ± 1.42 0.00 ± 0.00 0.00 ± 0.00 
ω3D before 12.18 ± 2.09 118.44 ± 4.76 1.01 ± 1.01 0.00 ± 0.00 
 after (1 wk) 12.30 ± 1.17 113.82 ± 3.49 0.91 ± 0.91 0.00 ± 0.00 
Table 4. Relative weight content (‰) of monodesaturated fatty acids in jejunum and caecum 
phospholipids 
3.2 Relation between intestinal and hepatic phospholipids 
In the case of long-chain polyunsaturated ω3 fatty acids, highly significant positive 
correlations prevailed between the relative content of C18:3ω3 in jejunal and hepatic 
phospholipids (r = + 0.8368; n = 12; p < 0.001), that of C22:5ω3 also in jejunal and hepatic 
phospholipids (r = + 0.9153; n = 12; p < 0.001), and that of C22:6ω3 either in jejunal and 
hepatic phospholipids (r = + 0.9716; n = 12; p < 0.001) or in caecal and hepatic phospholipids 
(r = + 0.8679; n = 12; p < 0.001). The paired ratio between the C22:6ω3 relative weight 
content in hepatic/jejunal phospholipids did not differ significantly (p > 0.14 or more) in the 
three groups of rats under consideration, i.e. control and ω3D rats examined at the end of 
the 3 months initial period and ω3D rats exposed for one week to the soya oil diet, with an 
overall mean value of 4.13 ± 0.16 (n = 12). 
In the case of long-chain polyunsaturated ω6 fatty acids, a significant positive correlation  
(r = + 0.5868; n = 12; p < 0.05) was found between the C22:4ω6 relative weight content of 
jejunal and hepatic phospholipids in the same 12 rats. Such was not the case (r = + 0.4924; n 
= 12; p > 0.1) for the C20:2ω6 content of the same phospholipids. The tightest correlations 
concerned the C22:5ω6 or liver phospholipids and that of either jejunal phospholipids (r = + 
0.9776; n = 12; p < 0.001) or caecal phospholipids (r = + 0.9242; n = 12; p < 0.001), with, in the 
latter two series of comparisons, either only one or no negative xy product among the 12 
sets of data. 
3.3 Fatty acid pattern of liver phospholipids 
3.3.1 Long-chain polyunsaturated ω3 fatty acids 
In fair agreement with the jejunal data, the relative weight content of C18:3ω3 in liver 
phospholipids averaged at the end of the initial 3 months period 0.35 ± 0.35‰ (n = 4) in the 
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ω3D rats, as distinct (p < 0.005) from 2.30 ± 0.19‰ (n = 4) in the control animals, increasing 
(p < 0.005) in the former ω3D rats to, respectively, 1.91 ± 0.09 and 2.09 ± 0.17‰ (n = 4 in both 
cases) one and two weeks after the switch to the soya oil diet. 
The relative weight content of the three other long-chain polyunsaturated ω3 fatty acids in 
liver phospholipids yielded comparable information (Table 5). First, the mean values 
recorded in the control animals before the switch in diet and 8 weeks thereafter never 
differed significantly (p > 0.6 or more) from one another, with overall mean values of 4.99 ± 
0.77‰ (n = 8) for C20:5ω3, 9.29 ± 0.58‰ (n = 8) for C22:5ω3 and 170.43 ± 2.92‰ (n = 8) for 
C22:6ω3. Second, these mean values were all significantly higher (p < 0.002 or less) than 
those recorded in the ω3D rats at the end of the 3 months initial period. Third, in the ω3D 
rats, higher values (p < 0.025 or less) were found after the switch in diet then before such a 
switch, with mean values over the 8 weeks exposure to the soya oil diet averaging 2.47 ± 
0.55‰ (n = 12) in the case of C20:5ω3, 7.15 ± 0.67‰ (n = 12) in the case of C22:5ω3 and 
130.02 ± 6.80‰ (n = 12) in the case of C22:6ω3. Last, the latter three percentages all remained 
significantly lower (p < 0.02 or less) than the corresponding mean values recorded in the 
control animals over the same period of 8 weeks. In the ω3D rats, a progressive time-related 
increase in the relative weight content of a long-chain polyunsaturated ω3 fatty acid in the 
liver phospholipids between the first and last week of exposure to the soya oil diet was only 
observed in the case of C22:6ω3 (r = + 0.6374; n = 12; p < 0.04). 
These findings indicate that, except as far as C18:3ω3 is concerned, a period of 8 weeks 
exposure of the ω3D rats to the soya oil diet was not quite sufficient to restore the liver 
phospholipid content of ω3 fatty acids to the same level as that otherwise found in control 
animals exposed to the same diet from the 8th week after birth. 
 
Rats C20:5ω3 C22:5ω3 C22:6ω3 
Control before 5.05 ± 1.12 9.00 ± 0.41 169.11 ± 4.49 
 after (8 wk) 4.93 ± 1.22 9.58 ± 1.17 171.81 ± 4.37 
ω3D before 0.00 ± 0.00 1.56 ± 0.80 54.52 ± 5.32 
 after (1 wk) 2.80 ± 1.40 6.81 ± 1.23 112.62 ± 8.54 
 after (2 wk) 1.90 ± 0.73 5.96 ± 0.33 128.16 ± 4.91 
 after (8 wk) 2.71 ± 0.85 8.68 ± 1.40 149.37 ± 13.55 
Table 5. Relative weight content (‰) of long-chain polyunsaturated ω3 fatty acids in liver 
phospholipids 
3.3.2 Long-chain polyunsaturated ω6 fatty acids 
Except in the case of C22:4ω6 and C22:5ω6, the mean values recorded in the control animals 
were not significantly different at the end of the 3 months initial period and 8 weeks 
thereafter (Table 6). In the former two cases, however, the mean values found at the end of 
the experiments were higher (p < 0.02 or less) than those recorded at the end of the 3 months 
initial period. 
No significant difference between the 6 groups of rats listed in Table 6 was observed for the 
C18:2ω6 relative weight content of liver phospholipids. Likewise, as far as C20:3ω6 is 
concerned, the mean value found in the control animals (7.28 ± 0.74‰; n = 8) did not differ 
significantly (p > 0.5) from that recorded in the ω3D rats (6.65 ± 0.64‰; n = 16) 
In the case of the other 5 long-chain polyunsaturated ω6 fatty acids (C20:2ω6, C18:3ω3, 
C20:4ω6, C22:4ω6 and C22:5ω6), the mean value found in the ω3D rats examined before the 
switch in diet always exceeded both that recorded in the 8 control animals and those 
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measured in each of the three groups of ω3D rats examined after the switch in diet. The 
relative magnitude of the difference between the values recorded in the ω3D rats before the 
switch from the sunflower oil diet to the soya oil diet and the overall mean value found in 
the control animals at the end of the initial 3 months period and 8 weeks thereafter was 
quite variable, ranging from as little as 12.0 ± 2.4% (df = 10; p < 0.001) in the case of C20:4ω6 
to as much as a tenfold increase (p < 0.001) in the case of C22:5ω6. 
 
Rats C18:2ω6 C20:2ω6 C18:3ω6 C20:3ω6 C20:4ω6 C22:4ω6 C22:5ω6 
Control before 82.51 ± 5.16 1.59 ± 0.18 1.72 ± 0.25 6.05 ± 0.63 303.65 ± 5.77 2.87 ± 0.16 5.27 ± 0.48 
             after (8 wk) 78.23 ± 4.70 1.57 ± 0.12 1.64 ± 0.06 8.52 ± 1.06 308.73 ± 8.17 3.99 ± 0.13 9.27 ± 1.07 
ω3D     before 77.83 ± 2.73 2.78 ± 0.80 2.03 ± 0.20 5.44 ± 0.44 342.83 ± 4.45 8.54 ± 0.31 72.67 ± 8.82 
             after (1wk) 74.16 ± 5.52 1.64 ± 0.17 1.85 ± 0.29 6.73 ± 1.51 330.74 ± 6.44 5.38 ± 0.04 37.21 ± 5.54 
             after (2 wk) 77.23 ± 2.55 1.94 ± 0.15 1.61 ± 0.13 6.19 ± 0.97 330.51 ± 2.11 4.63 ± 0.23 23.63 ± 2.55 
             after (8 wk) 76.92 ± 6.60 1.44 ± 0.05 1.74 ± 0.19 8.22 ± 1.84 324.40 ± 3.48 4.45 ± 0.25 14.71 ± 4.07 
Table 6. Relative weight content (‰) of long-chain polyunsaturated ω6 fatty acids in liver 
phospholipids 
However, when the values recorded in the ω3D rats 1 week, 2 weeks and 8 weeks after the 
switch in diet, in excess of the reference value found in control animals, were expressed 
relative to the difference between the measurements made in the ω3D rats before the switch 
in diet and the same reference value found in control animals, a time-related obliteration of 
the latter difference was often observed. As illustrated in Fig. 1, such a progressive decrease 
displayed an exponential pattern, with a half-life somewhat below one week. 
3.3.3 Saturated fatty acids 
Except in the case of C16:0 and C24:0 (p < 0.05 or less), no significant change was observed 
in the control animals between the liver phospholipid relative weight content of the six 
saturated fatty acids listed in Table 7, as measured at the end of the 3 months initial period 
and 8 weeks thereafter. 
 
Rats C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 
Control before 1.56 ± 0.15 133.92 ± 2.71 237.04 ± 4.67 0.70 ± 0.01 2.23 ± 0.69 6.84 ± 0.34 
 after (8 wk) 1.52 ± 0.11 120.29 ± 4.39 241.12 ± 5.76 0.75 ± 0.04 3.62 ± 0.13 8.79 ± 0.05 
ω3D before 1.86 ± 0.22 144.02 ± 5.75 273.82 ± 1.42 0.20 ± 0.20 4.42 ± 0.20 9.63 ± 0.24 
 after (1 wk) 1.74 ± 0.14 133.30 ± 3.77 261.74 ± 7.20 0.35 ± 0.20 2.78 ± 0.93 8.01 ± 0.16 
 after (2 wk) 1.81 ± 0.10 130.91 ± 1.67 252.75 ± 1.55 0.20 ± 0.20 3.42 ± 0.40 7.86 ± 0.05 
 after (8 wk) 1.51 ± 0.15 116.45 ± 4.95 251.72 ± 9.17 0.00 ± 0.00 3.34 ± 0.19 8.42 ± 0.56 
Table 7. Relative weight content (‰) of saturated fatty acids in liver phospholipids 
The C20:0 relative weight content of liver phospholipids was lower (p < 0.001) in the ω3D 
rats (0.19 ± 0.08‰; n = 16) than in the control animals (0.72 ± 0.02‰; n = 8). The opposite 
situation prevailed for the other five saturated fatty acids (C14:0, C16:0, C18:0, C22:0 and 
C24:0). As documented in Fig. 2, using the same analytical procedure as that applied to the 
data relative to content of long-chain polyunsaturated ω6 fatty acids (Fig. 1), the switch from 
the sunflower oil diet to the soya oil diet provoked a time-related normalization of the liver 
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phospholipid content of the just mentioned five saturated fatty acids, with a half-life close to 
one week. Such a progressive decrease represented a mirror image of the progressive 
increase in the C22:6ω3 relative weight content of liver phospholipids in the ω3D rats 
examined after the switch in diet, with again a half-life close to one week. 
 
 
 
 
 
 
Fig. 1. Time course for the changes in the relative weight content of C20:2ω6, C18:3ω6, 
C20:4ω6, C22:4ω6 and C22:5ω6 in the liver phospholipids of ω3D rats after the switch from 
the sunflower oil to soya oil diet. For each of these five fatty acids, all individual results are 
expressed relative to the difference between the mean value recorded in the ω3D rats before 
the switch in diet and the overall mean value found in the control animals examined at the 
end of the 3 months initial period and 8 weeks thereafter. Mean values (± SEM) refer to 20 
individual measurements in the ω3D rats (closed circles) and 40 individual measurements in 
the control animals (open circle) 
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Fig. 2. Time course for the changes in the relative weight content of C14:0, C16:0, C18:0, 
C22:0 and C24:0 in the liver phospholipids of ω3D rats after the switch from the sunflower 
oil to soya oil diet. Same presentation as in Fig. 1. The inset illustrates the time course for the 
changes in the relative weight content (%) of C22:6ω3 in the liver phospholipids of control 
animals (open circles and dashed line) and ω3D rats (closed circles and solid line); mean 
values (± SEM) refer to 4 individual determinations in each case. 
3.3.4 Monodesaturated fatty acids 
No significant difference in the relative weight content of monodesaturated fatty acids 
(C16:1ω7, C18:1ω9, C20:1ω9 and C22:1ω9) in liver phospholipids was detected when 
comparing control animals and ω3D rats, whether examined at the end of the 3 months 
initial period or thereafter (Table 8). For instance, the C22:1ω9 content averaged 2.08 ± 
0.20‰ (n = 8) in the control animals, and respectively 2.92 ± 0.63‰ (n = 4) and 2.74 ± 0.40‰ 
(n = 12) in the ω3D rats examined before and after the switch in diet. None of the latter three 
percentages differed significantly from one another (p > 0.2 or more). 
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Rats C16:1ω7 C18:1ω9 C20:1ω9 C22:1ω9 
Control before 5.16 ± 1.06 23.91 ± 2.57 0.33 ± 0.19 2.04 ± 0.24 
 after (1 wk) 6.14 ± 0.44 23.04 ± 0.80 0.00 ± 0.00 2.11 ± 0.37 
ω3D before 5.83 ± 0.96 27.04 ± 2.78 0.00 ± 0.00 2.92 ± 0.63 
 after (1 wk) 5.20 ± 1.02 23.79 ± 2.17 0.16 ± 0.16 2.05 ± 0.49 
 after (2 wk) 5.57 ± 0.74 24.90 ± 1.35 0.00 ± 0.00 2.12 ± 0.54 
 after (8 wk) 5.75 ± 0.78 24.58 ± 1.46 0.00 ± 0.00 4.06 ± 0.57 
Table 8. Relative weight content (‰) of monodesaturated fatty acids in liver phospholipids 
3.4 Fatty acid pattern of RBC phospholipids 
3.4.1 Long-chain polyunsaturated ω3 fatty acids 
The mean values for the relative weight content of long-chain polyunsaturated ω3 fatty 
acids in RBC phospholipids are listed in Table 9. 
In the ω3D rats, the C18:3ω3 relative weight content of RBC phospholipids increased (p < 
0.005) from a mean value of 0.62 ± 0.36‰ (n = 4) before the switch in diet to an overall mean 
value of 1.79 ± 0.07‰ (n = 6) thereafter. The latter mean value remained somewhat lower (p 
< 0.06) than that recorded in the control animals at the end of the 3 months initial period 
(2.11 ± 0.14‰; n = 4). A minor amount of C18:4ω3 (1.60 ± 0.21‰; n = 4) was only detected in 
the ω3D rats examined before the switch in diet. 
 
Rats C18:3ω3 C20:5ω3 C22:5ω3 C22:6ω3 
Control before 2.11 ± 0.14 4.33 ± 0.57 19.11 ± 0.64 68.11 ± 1.39 
 after (8 wk) N.T. 3.01 ± 0.37 21.37 ± 2.25 64.84 ± 2.84 
ω3D before 0.62 ± 0.36 0.00 ± 0.00 1.82 ± 0.14 19.76 ± 1.12 
 after (1 wk) 1.88 (1) 1.06 (1) 4.53 (1) 27.75 (1) 
 after (2 wk) 1.69 (1) 1.36 (1) 5.80 (1) 36.31 (1) 
 after (8 wk) 1.79 ± 0.10 2.86 ± 0.35 14.02 ± 1.10 49.64 ± 3.84 
Table 9. Relative weight content (‰) of long-chain polyunsaturated ω3 fatty acids in RBC 
phospholipids 
In the ω3D rats, the C20:5ω3 content of RBC phospholipids also progressively increased 
from 0.00 ± 0.00‰ (n = 4) before the switch in diet to 1.21 ± 0.15‰ (n = 2) one to two weeks 
thereafter and 2.86 ± 0.35‰ (n = 4) 8 weeks thereafter. Once again, the latter mean value 
remained lower (p < 0.05) than that recorded in the control animals over the same period of 
8 weeks (4.12 ± 0.33‰; n = 8). The time-related increase in the C20:5ω3 content of RBC 
phospholipids was less rapid than that found, in the same ω3D rats, for the C20:5ω3 content 
of liver phospholipids. Indeed the paired RBC/liver ratio for such contents increased in the 
ω3D rats from 0.0 ± 0.0% (n = 4) before the switch in diet to respectively 37.9% (n = 1), 71.6% 
(n = 1) and 120.9 ± 17.2% (n = 4) one, two and 8 weeks thereafter. The latter mean value was 
no more significantly different (p > 0.25) from the RBC/liver ratio found in the control 
animals examined either before (98.6 ± 19.6%; n = 4) or after (90.6 ± 16.7%; n = 4) the last 8 
weeks of the present experiments. 
A delayed alignment of the C22:5ω3 content of RBC phospholipids on that of liver 
phospholipids in the ω3D rats eventually exposed to the soya oil diet was also observed, as 
illustrated in Fig. 3. Thus, the liver/RBC ratio for this variable transiently increased in the 
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ω3D rats switched to the soya oil diet before resuming a mean value (60.9 ± 5.4%; n = 4) still 
somewhat higher (p < 0.02) than that recorded in the control animals over the same period 
of 8 weeks (46.2 ± 2.5%; n = 8). 
 
 
Fig. 3. Time course for the changes in the RBC/liver ratio for the C22:5ω3 (left) and C22:6ω3 
(right) relative weight content of phospholipids in control animals (open circles and dashed 
line) and ω3D rats (closed circles and solid line). Single measurements made in pooled 
samples from 4 rats (week 1 and 2) or mean values (± SEM; n = 4) are expressed relative to 
the mean value found in the ω3D rats before the switch in diet. 
Likewise, the liver/RBC ratio for the C22:6ω3 content of phospholipids transiently increased 
in the ω3D rats exposed to the soya oil diet before resuming a mean value of 300.0 ± 6.2% (n 
= 4), still somewhat higher (p < 0.003) than that recorded in the control animals  over the 
same period of 8 weeks (257.9 ± 7.9%; n = 8). Incidentally, Fig. 3 also documents that, in the 
control animals, the liver/RBC ratio for either the C22:5ω3 or C22:6ω3 content of 
phospholipids was not significantly different (p > 0.27 or more) at the onset and end of the 
last 8 weeks period in the present experiments, as also observed (p > 0.7) for the RBC/liver 
ratio for the C20:5ω3 content of phospholipids in the control animals (see above). 
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3.4.2 Long-chain polyunsaturated ω6 fatty acids 
A mirror image of that recorded for C22:5ω3 or C22:6ω3 was observed concerning the 
liver/RBC ratio for the relative weight content of C22:4ω6. Thus, such a ratio, which was 
significantly higher (p < 0.001) in the ω3D rats (33.9 ± 1.1%; n = 4) than in the control rats 
(21.7 ± 1.3%; n = 4) both examined at the end of the 3 months initial period, first decreased 
(p < 0.025) in the ω3D rats to 22.0 ± 0.1% (n = 2) one to two weeks after the switch in diet and 
then increased again (p < 0.02) to 27.0 ± 1.4% (n = 4) 8 weeks after the switch in diet, 
reaching a value virtually identical (p > 0.49) to that recorded at the same time in the control 
animals (28.5 ± 1.5%; n = 4). In the case of C22:5ω6, the liver/RBC ratio was again 
significantly higher (p < 0.001) in the ω3D rats (230.2 ± 9.9%; n = 4) than in the control 
animals (95.5 ± 4.4%; n = 4) both examined at the end of the 3 months initial period. It 
decreased (p < 0.005) in the ω3D rats to 124.5 ± 9.3% (n = 2) one to two weeks after the 
switch in diet, such a value being comparable to that reached 8 weeks after the switch in diet 
(125.6 ± 14.3%; n = 4) in the ω3D rats. The latter two mean values were no more significantly 
different (p > 0.25) than that recorded in the control animals at the end of the present 
experiments (149.2 ± 13.3%; n = 4) and virtually identical to that prevailing in the same 
animals over the last 8 weeks of such experiments (122.4 ± 12.0%; n = 8). 
 
Rats C18:2ω6 C18:3ω6 C20:2ω6 C20:3ω6 C20:4ω6 C22:4ω6 C22:5ω6 
Control before 80.09 ± 4.08 0.17 ± 0.17 0.00 ± 0.00 4.44 ± 0.20 330.00 ± 6.00 13.35 ± 0.79 5.48 ± 0.31 
            after (8 wk) 72.40 ± 4.76 0.79 ± 0.28 0.38 ± 0.38 5.78 ± 0.55 329.36 ± 3.91 14.06 ± 0.44 6.23 ± 0.44 
ω3D before 78.13 ± 0.51 0.22 ± 0.22 0.00 ± 0.00 3.69 ± 0.22 341.09 ± 10.40 25.21 ± 0.43 31.37 ± 3.06 
            after (1 wk) 69.30 (1) 0.00 (1) 0.00 (1) 4.45 (1) 347.89 (1) 24.37 (1) 27.82 (1) 
            after (2 wk) 78.11 (1) 0.00 (1) 1.86 (1) 4.23 (1) 350.33 (1) 21.10 (1) 20.50 (1) 
           after (8 wk) 75.82 ± 4.75 0.00 ± 0.00 0.96 ± 0.55 5.42 ± 0.48 335.95 ± 2.91 16.57 ± 0.14 11.21 ± 1.73 
Table 10. Relative weight content (‰) of long-chain polyunsaturated ω6 fatty acids in RBC 
phospholipids 
3.4.3 Saturated fatty acids 
Significant differences were also on occasion observed when comparing the relative weight 
content of selected saturated fatty acids in the RBC phospholipids of control and ω3D rats 
(Table 11). For instance, the content of C18:0 averaged 178.46 ± 2.09‰ (n = 8) in control 
animals, as distinct (p < 0.003) from 188.11 ± 1.64‰ (n = 10) in ω3D rats. Inversely, the C24:0 
content of RBC phospholipids was higher (p < 0.025) in the control animals (17.05 ± 0.87‰; n = 
8) than in the ω3D rats examined before the switch in diet (13.46 ± 0.52‰; n = 4), reascending 
(p < 0.001) to 18.50 ± 0.68‰ (n = 6) when the latter ω3D rats were switched to the soya oil diet. 
 
Rats C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 
Control before 1.36 ± 0.04 212.94 ± 3.33 179.33 ± 2.25 1.15 ± 0.04 6.38 ± 0.26 15.03 ± 0.77 
                after (8 wk) 1.51 ± 0.07 217.35 ± 2.26 177.60 ± 3.84 1.00 ± 0.34 7.50 ± 0.32 19.08 ± 0.46 
ω3D before 1.50 ± 0.06 219.93 ± 8.24 189.75 ± 3.12 1.23 ± 0.08 6.52 ± 0.33 13.46 ± 0.52 
               after (1 wk) 1.44 (1) 218.9 (1) 187.6 (1) 1.42 (1) 7.52 (1) 16.10 (1) 
               after (2 wk) 1.44 (1) 205.6 (1) 184.9 (1) 1.33 (1) 7.77 (1) 17.84 (1) 
               after (8 wk) 1.46 ± 0.08 210.37 ± 3.67 187.4 ± 2.93 1.31 ± 0.10 8.16 ± 0.54 19.27 ± 0.66 
Table 11. Relative weight content (‰) of saturated fatty acids in RBC phospholipids 
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3.4.4 Monodesaturated fatty acids 
The C16:1ω7 relative weight content of RBC phospholipids averaged 2.90 ± 0.15‰ (n = 8) in 
the control animals, and 2.58 ± 0.41‰ (n = 4) and 2.96 ± 0.21‰ (n = 6) in the ω3D rats 
examined, respectively, before and after the switch in diet. The corresponding values for the 
C18:1ω9 content of RBC phospholipids averaged 53.08 ± 1.46‰ (n = 8), 52.91 ± 2.47‰ (n = 4) 
and 54.47 ± 1.56‰ (n = 6). No C20:1ω9 was detected in any of the 18 samples concerned by 
this study. Sizeable amounts of C22:1ω9 (8.14 ± 0.20‰; n = 4) were only detected in the 
samples prepared from the ω3D rats examined before the switch in diet. 
3.5 Fatty acid pattern of brain phospholipids 
3.5.1 Long-chain polyunsaturated ω3D fatty acids 
No C18:3ω3, C18:4ω3 or C20:5ω3 was detected in any of the 20 samples examined for the 
fatty acid pattern of brain phospholipids. The C22:5ω3 and C22:6ω3 relative weight content 
of brain phospholipids were significantly lower in ω3D rats than in control animals both 
examined at the end of the 3 months initial period and, in the former ω3D rats, slowly 
returned towards control values after the switch in diet (Table 12). 
 
Rats C22:5ω3 C22:6ω3 
Control before 2.29 ± 0.04 235.93 ± 6.60 
            after (8 wk) 2.30 ± 0.20 213.34 ± 7.43 
ω3D before 0.00 ± 0.00 186.65 ± 5.01 
            after (1 wk) 0.27 ± 0.27 193.19 ± 3.72 
            after (8 wk) 1.95 ± 0.14 209.04 ± 4.89 
Table 12. Relative weight content (‰) of long-chain polyunsaturated ω3 fatty acids in brain 
phospholipids 
3.5.2 Long-chain polyunsaturated ω6 fatty acids 
The C18:2ω6 relative weight content of brain phospholipids was higher (p < 0.02) in the 
control animals (7.30 ± 0.24%; n = 8) than in the ω3D rats examined before and one week 
after the switch in diet (6.27 ± 0.29‰; n = 8), resuming in the ω3D rats exposed for 8 weeks 
to the soya oil diet a mean value (7.55 ± 0.14‰; n = 4) no more significantly different (p > 
0.5) from that recorded in the control animals (Table 13). A comparable situation prevailed 
 
Rats C18:2ω6 C20:2ω6 C20:3ω6 C20:4ω6 C22:4ω6 C22:5ω6 
Control before 7.16 ± 0.39 1.31 ± 0.06 2.48 ± 0.09 131.66 ± 6.04 26.85 ± 1.70 3.12 ± 0.23 
 after (8 wk) 7.45 ± 0.31 1.56 ± 0.13 2.99 ± 0.17 116.71 ± 8.21 27.23 ± 0.93 3.08 ± 0.37 
ω3D  before 6.27 ± 0.58 1.34 ± 0.14 2.07 ± 0.21 137.94 ± 7.23 30.21 ± 1.63 22.94 ± 1.46 
 after (1 wk) 6.27 ± 0.20 1.48 ± 0.07 2.30 ± 0.19 125.04 ± 3.90 28.88 ± 1.40 19.00 ± 1.41 
 after (8 wk) 7.55 ± 0.14 1.48/1.58 2.55 ± 0.15 122.74 ± 3.38 26.49 ± 2.79 8.30 ± 0.54 
Table 13. Relative weight content (‰) of long-chain polyunsaturated ω6 fatty acids in brain 
phospholipids 
 in the case of C20:3ω6, with a lower value (p < 0.025) in ω3D rats (2.31 ± 0.11‰; n = 12) than 
in control animals (2.74 ± 0.13‰; n = 18). Except in one control animal with a C18:3ω6 
relative content of 0.79‰ in brain phospholipids, no sizeable amount of this fatty acid could 
be detected in any of the other 19 samples. In the case of both C22:4ω6 and C22:5ω6, the 
mean value recorded at the end of the initial 3 months period was higher in ω3D rats than in 
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control animals, a progressive decrease being recorded in the former ω3D rats after the 
switch in diet. Such changes were most obvious in the case of C22:5ω6. 
3.5.3 Saturated fatty acids 
As a rule, the relative weight content of saturated fatty acids in the brain phospholipids of 
ω3D rats were comparable to the overall mean values found in control animals (Table 14). In 
the case of C14:0 and C16:0, however, the individual values collected in ω3D rats differed 
significantly (p < 0.004) from those recorded in control animals, averaging 114.0 ± 3.1%  
(n = 24) of the mean corresponding measurements made in the latter control animals (100.0 
± 2.5%; n = 16). 
 
Rats C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 
Control before 1.03 ± 0.06 228.96 ± 6.45 184.97 ± 2.01 3.06 ± 0.14 2.90 ± 0.18 6.90 ± 0.58 
 after (8 wk) 0.92 ± 0.04 194.74 ± 5.20 193.39 ± 2.13 5.31 ± 0.91 5.50 ± 0.79 12.95 ± 1.42 
ω3D before 1.11 ± 0.07 232.34 ± 6.19 188.85 ± 2.19 3.44 ± 0.38 3.54 ± 0.80 8.65 ± 1.62 
 after (1 wk) 1.15 ± 0.03 231.48 ± 8.04 182.90 ± 2.40 4.32 ± 0.44 4.41 ± 0.46 10.13 ± 0.98 
 after (8 wk) 1.21 ± 0.13 231.30 ± 22.37 186.66 ± 6.29 3.89 ± 0.40 4.09 ± 0.76 9.08 ± 1.84 
Table 14. Relative weight content (‰) of saturated fatty acids in brain phospholipids 
3.5.4 Monodesaturated fatty acids 
In the same manner as noticed in the case of most saturated fatty acids, the relative weight 
content of monodesaturated fatty acids in brain phospholipids displayed in the ω3D rats 
values not vastly different from the overall mean values recorded in control animals (Table 
15). Thus, relative to the latter overall mean values for each monodesatuarted fatty acids 
found in control animals (100.0 ± 12.9%; n = 32), those recorded in the ω3D rats averaged 
100.0 ± 7.1%; n = 48). 
 
Rats C16:1ω7 C18:1ω9 C20:1ω9 C22:1ω9 
Control before 3.20 ± 0.16 149.78 ± 3.34 8.39 ± 1.01 0.00 ± 0.00 
           after (9 wk) 3.36 ± 0.13 187.77 ± 13.66 16.71 ± 2.21 2.73 ± 1.04 
ω3D before 3.05 ± 0.24 161.33 ± 13.22 9.70 ± 2.38 0.58 ± 0.58 
           after (1 wk) 3.12 ± 0.08 171.48 ± 6.09 12.37 ± 2.34 2.19 ± 0.32 
           after (8 wk) 3.34 ± 0.15 168.53 ± 7.92 10.40 ± 1.32 2.06 ± 0.71 
Table 15. Relative weight content (‰) of monodesaturated fatty acids in brain 
phospholipids 
3.5.5 Comparison of brain, RBC and liver data 
As already observed, in the case of RBC phospholipids, the changes in the relative weight 
content of selected fatty acids in brain phospholipids, as recorded in the ω3D rats after the 
switch from the sunflower oil diet to the soya oil diet, occurred less rapidly than those found 
in liver phospholipids. In such a respect, there was no significant difference (p > 0.6 or 
more) when comparing the data collected in either the RBC or brain phospholipids. For 
instance, in the case of C22:5ω3 and C22:6ω3, the increment found in the ω3D rats examined 
one week after the switch in diet, above the mean value recorded before such a switch, only 
represented, in brain and RBC respectively, 21.6 ± 10.5% (n = 8) and 26.0 ± 3.8% (n = 2) of the 
corresponding mean increment found 8 weeks after the switch in diet. The latter 
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percentages yielded an overall mean value of 22.5 ± 8.3% (n = 10), significantly lower (p < 
0.004) than that recorded under the same experimental conditions in liver, i.e. 67.5 ± 9.3% (n 
= 8). Likewise, in the case of C22:4ω6 and C22:5ω6, the decrement recorded in the ω3D rats 
one week after the switch in diet, below the mean corresponding reference values found 
before such a switch, yielded in the brain and RBC, when expressed relative to the 
corresponding mean decrement observed 8 weeks after the switch in diet, an overall mean 
value of 27.8 ± 14.4% (n = 10), significantly lower (p < 0.03) than that recorded under the 
same experimental conditions in liver,  i.e. 69.2 ± 5.4% (n = 8). The latter two mean values 
relative to two long-chain polyunsaturated ω6 fatty acids were virtually identical (p > 0.75 
or more) to the corresponding mean values found in the case of the two long-chain 
polyunsaturated ω3 fatty acids under consideration (see above), yielding overall mean 
percentages of 25.1 ± 8.1% (n = 20) in brain and RBC, as compared (p < 0.001) to 68.4 ± 5.2% 
(n = 16) in liver. 
3.6 Fatty acid pattern in liver triglycerides 
The total fatty acid content of liver triglycerides did not differ significantly (p > 0.64) in the 
control animals and ω3D rats, with an overall mean values of 18.3 ± 2.5 mg/g wet wt. (n = 24). 
3.6.1 Long-chain polyunsaturated ω3 fatty acids 
The relative weight content of C18:3ω3, C20:5ω3, C22:5ω3 and C22:6ω3 in liver triglycerides 
was significantly lower (p < 0.02 or less) in the ω3D rats than in the control animals, both 
examined at the end of the 3 months initial period (Table 16). In the control animals, no 
significant difference was observed between the former results and those recorded 8 weeks 
later. In the ω3D rats examined after the switch in diet, C20:5ω3 remained below the limit of 
detection in all, except one, rats. The C18:3ω3, C22:5ω3 and C22:6ω3 contents increased, 
however, in the ω3D rats within one week after the switch in diet, remaining then at a 
plateau level somewhat lower than the mean value otherwise found in control rats. Thus, 
relative to such a reference value (100.0 ± 7.9%; n = 24), the measurements made in the ω3D 
rats examined after the switch in diet averaged 66.1 ± 5.3% (n = 36; p < 0.001). 
 
Rats C18:3ω3 C20:5ω3 C22:5ω3 C22:6ω3 
Control before 12.82 ± 2.96 2.01 ± 0.27 3.41 ± 0.56 7.04 ± 1.08 
           after (8 wk) 11.94 ± 3.03 1.61 ± 0.51 3.06 ± 0.90 6.45 ± 1.20 
ω3D before 1.81 ± 0.69 0.00 ± 0.00 0.00 ± 0.00 0.48 ± 0.48 
           after (1 wk) 8.86 ± 2.26 0.00 ± 0.00 1.81 ± 0.83 3.66 ± 1.48 
           after (2 wk) 10.23 ± 0.56 0.00 ± 0.00 2.07 ± 0.19 4.55 ± 0.47 
           after (8 wk) 8.84 ± 1.99 0.12 ± 0.12 1.81 ± 0.55 4.80 ± 1.70 
Table 16. Relative weight content (‰) in long-chain polyunsaturated ω3 fatty acids in liver 
triglycerides 
3.6.2 Long-chain polyunsaturated ω6 fatty acids 
The C18:2ω6 relative weight content of liver triglycerides was virtually identical in control 
animals and ω3D rats, whether at the onset or end of the last 8 weeks period of the present 
experiments (Table 17). Likewise, no significant difference was found between the mean 
values found in the six groups of rats when considering the relative weight content of C18:3ω6, 
C20:2ω6 and C20:3ω6 in the liver triglycerides. In the case of C20:4ω6, C22:4ω6 and C22:5ω6, 
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no significant difference (p > 0.3 or more) was observed between the control animals examined 
either at the end of the initial period or 8 weeks thereafter. In the ω3D rats, the C20:4ω6 content 
progressively decreased as a function of the length of exposure to the soya oil diet (r = - 0.5059; 
n = 16; p < 0.05), eventually reaching a mean value comparable (p > 0.9) to that recorded at the 
same time in the control animals. A comparable situation prevailed in the case of C22:4ω6 and 
C22:5ω6. Thus, for the last three fatty acids (C20:4ω6, C22:4ω6 and C22:4ω6), the increment in 
the relative weight content found in ω3D rats above the mean corresponding value (n = 8 in 
each case) recorded in the control animals, when expressed relative to the initial increment 
found before the switch in diet, decreased (p < 0.02) from 100.0 ± 17.5% (n = 12) to 49.6 ± 11.3% 
(n = 24) one to two weeks after the switch in diet and further decreased (p < 0.025) to 3.6 ± 
15.6% (n = 12) eight weeks after the switch in diet. 
 
Rats C18:2ω6 C18:3ω6 C20:2ω6 C20:3ω6 C20:4ω6 C22:4ω6 C22:5ω6 
Control  before 235.21 ± 34.54 5.35 ± 0.38 1.78 ± 0.09 1.65 ± 0.22 20.14 ± 2.57 2.61 ± 0.63 0.73 ± 0.45 
                after (8 wk)174.06 ± 38.86 4.44 ± 0.88 1.80 ± 0.17 1.78 ± 0.49 15.22 ± 4.02 2.92 ± 0.59 0.72 ± 0.27 
ω3D        before 237.23 ± 42.90 6.17 ± 0.88 1.75 ± 0.65 1.92 ± 0.83 33.92 ± 6.30 6.15 ± 1.30 4.62 ± 0.78 
                after (1 wk)194.60 ± 39.29 5.01 ± 0.45 1.94 ± 0.34 1.65 ± 0.22 23.07 ± 6.69 4.49 ± 1.47 3.17 ± 1.08 
                after (2 wk)218.50 ± 30.62 4.73 ± 0.30 1.73 ± 0.60 2.24 ± 0.50 24.75 ± 3.55 4.93 ± 0.86 2.42 ± 0.55 
                after (8 wk)173.01 ± 45.75 4.25 ± 0.66 1.76 ± 0.27 1.79 ± 0.63 16.08 ± 5.93 3.29 ± 1.08 0.93 ± 0.55 
Tale 17. Relative weight content (‰) of long-chain polyunsaturated ω6 fatty acids in liver 
triglycerides 
3.6.3 Saturated fatty acids 
The C12:0 relative weight content of liver triglycerides averaged 0.72 ± 0.16‰ (n = 8) and 
0.35 ± 0.12‰ (n = 16) in the control animals and ω3D rats, respectively, these two mean 
values failing to differ significantly (p < 0.09) from one another. Likewise, the C14:0, C16:0 
and C18:0 contents of liver triglycerides were essentially comparable in the six groups of 
rats considered in Table 18. A significant amount of C20:0 (0.37 ± 0.14‰; n = 8; p < 0.05) was 
detected in the control animals, whilst such was not the case (0.02 ± 0.02‰; n = 16; p > 0.3) 
in the ω3D rats. Inversely, a significant amount of C22:0 (0.52 ± 0.17‰; n = 12; p < 0.02) was 
detected in the ω3D rats examined before the switch in diet and one to two weeks thereafter, 
whilst such was no more the case 8 weeks after the switch in diet, null values being also 
recorded in the 8 control animals.  No C24:0 was detected in any of the 24 samples examined 
in this study. 
 
Rats C12:0 C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 
Control before 0.77 ± 0.26 11.54 ± 1.47 291.91 ± 14.36 21.83 ± 2.40 0.41 ± 0.23 0.00 ± 0.00 0.00 ± 0.00 
               after (8 wk) 0.70 ± 0.24 14.22 ± 2.13 345.81 ± 27.78 25.09 ± 3.20 0.33 ± 0.21 0.00 ± 0.00 0.00 ± 0.00 
ω3D       before 0.21 ± 0.21 11.92 ± 1.75 307.56 ± 20.99 29.56 ± 3.48 0.00 ± 0.00 0.66 ± 0.38 0.00 ± 0.00 
               after (1 wk) 0.73 ± 0.24 13.54 ± 1.17 349.41 ± 34.67 27.83 ± 2.86 0.00 ± 0.00 0.34 ± 0.07 0.00 ± 0.00 
               after (2 wk) 0.00 ± 0.00 13.54 ± 1.59 304.80 ± 16.14 24.35 ± 1.64 0.00 ± 0.00 0.56 ± 0.41 0.00 ± 0.00 
               after (8 wk) 0.45 ± 0.27 15.13 ± 1.74 344.48 ± 35.98 28.62 ± 2.99 0.08 ± 0.08 0.00 ± 0.00 0.00 ± 0.00 
Table 18. Relative weight content (‰) of saturated fatty acids in liver triglycerides 
3.6.4 Monodesaturated fatty acids 
No significant difference in the relative weight content of either C16:1ω7 or C18:1ω9 in liver 
triglycerides was observed between the six groups of rats listed in Table 19. Except in one 
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instance, such was also the case for the C20:1ω9 content of liver triglycerides. No C22:1ω9 
was detected in any of the 24 samples under consideration. The sole statistically significant 
finding consisted in the positive correlation (r = + 0.9958; n = 4; p < 0.01) prevailing between 
the mean values for the C16:1ω7 and C18:1ω9 relative content recorded in the ω3D rats (all 
expressed relative to the mean corresponding value found in the eight control animals) and 
the length of exposure to the soya oil diet (semi-logarithmic analysis). Indeed, relative to 
such a reference value (100.0 ± 4.9%; n = 16), the measurements made in the ω3D rats 
averaged 85.7 ± 6.9% (n = 8) before the switch in diet and 91.9 ± 5.7% (n = 8), 93.9 ± 6.6% (n = 
8) and 101.5 ± 6.7% (n = 8), respectively, one, two and eight weeks thereafter. 
 
Rats C16:1ω7 C18:1ω9 C20:1ω9 C22:1ω9 
Control before 54.15 ± 9.90 325.12 ± 16.65 1.30 ± 0.13 0.00 ± 0.00 
           after (8 wk) 65.55 ± 5.93 322.72 ± 13.35 1.28 ± 0.15 0.00 ± 0.00 
ω3D before 45.40 ± 6.55 309.22 ± 20.00 1.27 ± 0.49 0.00 ± 0.00 
           after (1 wk) 53.92 ± 6.96 303.93 ± 11.47 1.37 ± 0.49 0.00 ± 0.00 
           after (2 wk) 51.78 ± 7.12 327.78 ± 16.36 1.42 ± 0.49 0.00 ± 0.00 
           after (8 wk) 59.68 ± 8.20 334.84 ± 14.10 0.41 ± 0.25 0.00 ± 0.00 
Table 19. Relative weight content (‰) of monodesaturated fatty acids in liver triglycerides 
3.7 Fatty acid profile of visceral adipose tissue lipids 
As indicated in Table 20, no significant difference was observed between control animals 
and ω3D rats in terms of body weight and visceral or parametrial adipose tissue weight, 
whether at the end of the 3 months initial period or 8 weeks thereafter. 
 
Rats Body wt (g) Visceral adipose tissue (g) Parametrial adipose tissue (g) 
Control before 360.5 ± 17.6 9.5 ± 1.4 16.0 ± 3.4 
                after (8 wk) 463.0 ± 18.8 16.5 ± 2.1 23.0 ± 3.2 
ω3D before 380.5 ± 21.8 13.5 ± 1.6 14.1 ± 4.0 
                after (8 wk) 445.8 ± 49.1 12.3 ± 1.8 19.1 ± 1.1 
Table 20. Body weight and visceral or parametrial adipose tissue weight 
The total fatty acid content of visceral adipose tissue lipids was not significantly different (p 
> 0.5) in control animals (1.19 ± 0.03 mg/mg wet wt.; n = 8) and ω3D rats (1.21 ± 0.03 
mg/mg wet wt.; n = 8). 
3.7.1 Long-chain polyunsaturated ω3 fatty acids 
No C18:4ω3 or C20:5ω3 was detected in any of the 16 samples of adipose tissue. 
The C18:3ω3 relative weight content averaged 20.36 ± 0.83 and 18.39 ± 0.62‰ (n = 4 in both 
cases) in the control animals examined at the end of the 3 months initial period and 8 weeks 
thereafter. In the ω3D rats, it increased (p < 0.001) from 0.00 ± 0.00 to 11.67 ± 0.92‰ (n = 4 in 
both cases) before and 8 weeks after the switch in diet. It thus remained lower (p < 0.001) in 
the ω3D rats than in the control animals even at the end of the experiments. 
The C22:5ω3 content of adipose tissue was comparable at the end of the 3 months initial 
period and 8 weeks thereafter, with overall mean values of 1.21 ± 0.11‰ (n = 8) in control 
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animals and 0.00 ± 0.00‰ (n = 8) in ω3D rats. Likewise, no C22:6ω3 was detected in any of 
the eight ω3D rats, as distinct (p < 0.05) from an overall mean value of 1.14 ± 0.44‰ in the 
eight control animals (Table 21). 
 
Rats C18:3ω3 C20:5ω3 C22:5ω3 C22:6ω3 
Control before 20.36 ± 0.83 0.00 ± 0.00 1.11 ± 0.19 0.00 ± 0.00 
             after (8 wk) 18.39 ± 0.62 0.00 ± 0.00 1.32 ± 0.12 2.29 ± 0.21 
ω3D before 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
            after (8 wk) 11.67 ± 0.92 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Table 21. Relative weight content (‰) of long-chain polyunsaturated ω3 fatty acids in 
visceral adipose tissue lipids 
3.7.2 Long-chain polyunsaturated ω6 fatty acids 
The C18:2ω6 relative weight content of adipose tissue lipids was comparable (p > 0.45 or 
more) in control animals and ω3D rats, whether at the onset or end of the last 8 weeks 
period (Table 22). 
 
Rats C18:2ω6 C20:2ω6 C20:3ω6 C20:4ω6 C22:4ω6 C22:5ω6 
Control before 303.06 ± 13.00 2.52 ± 0.06 0.00 ± 0.00 6.72 ± 1.13 1.28 ± 0.29 0.00 ± 0.00 
 after (8 wk) 276.14 ± 3.41 2.57 ± 0.05 0.36 ± 0.36 6.52 ± 0.48 1.50 ± 0.17 0.14 ± 0.14 
ω3D before 324.61 ± 23.71 2.67 ± 0.10 0.00 ± 0.00 8.21 ± 0.93 2.09 ± 0.25 1.45 ± 0.21 
 after (8 wk) 288.77 ± 19.45 2.46 ± 0.04 0.36 ± 0.36 6.94 ± 0.35 1.56 ± 0.11 0.63 ± 0.25 
Table 22. Relative weight content (‰) of long-chain polyunsaturated ω6 fatty acids in 
visceral adipose tissue lipids 
No C18:3ω6 was detected in any of the 16 samples under consideration. The C20:2ω6 
content was comparable in the 4 groups of rats. A sizeable amount of C20:3ω6 (1.46 ± 0.00; n 
= 2) was only detected in two out of 16 samples. The C20:4ω6 content was not significantly 
higher (p > 0.1) in the ω3D rats examined before the switch in diet (8.21 ± 0.93‰; n = 4) than 
in the other rats (6.73 ± 0.39‰; n = 12). The C22:4ω6 content was significantly higher (p < 
0.02), however, in the ω3D rats examined before the switch in diet (2.09 ± 0.25‰; n = 4) than 
in the other animals (1.45 ± 0.11‰; n = 12). Likewise, the C22:5ω6 content found in the ω3D 
rats examined before the switch in diet (1.45 ± 0.21‰; n = 4) exceeded (p < 0.05 or less) that 
found in either the control animals (0.07 ± 0.07‰; n = 8) or the ω3D rats examined 8 weeks 
after the switch in diet (0.63 ± 0.25‰; n = 4). 
3.7.3 Saturated fatty acids 
The relative weight content of C12:0, C14:0, C16:0 and C18:0 were comparable to one 
another in the four groups of rats (Table 23). The sole significant difference (p < 0.02) 
 
Rats C12:0 C14:0 C16:0 C18:0 
Control before 0.72 ± 0.09 9.57 ± 0.93 253.51 ± 5.71 30.07 ± 1.20 
 after (8 wk) 0.68 ± 0.04 9.52 ± 0.59 264.89 ± 2.80 30.26 ± 0.76 
ω3D before 0.77 ± 0.07 10.57 ± 1.13 253.17 ± 11.65 34.09 ± 1.78 
 after (8 wk) 0.74 ± 0.05 10.48 ± 0.59 261.90 ± 7.80 29.79 ± 1.61 
Table 23. Relative weight content (‰) of saturated fatty acids in visceral adipose tissue 
lipids 
www.intechopen.com
 Soybean and Health 
 
76
concerned the comparison between the C18:0 content of the ω3D rats examined before the 
switch in diet (34.1 ± 1.8‰; n = 4) and the other animals (30.0 ± 0.7‰; n = 12). 
No C20:0 or C24:0 was detected in any of the 16 samples of adipose tissue. A sizeable 
amount of C22:0 (0.55 ± 0.04‰; n = 2) was only found in two out of four ω3D rats examined 
before the switch in diet. 
3.7.4 Monodesaturated fatty acids 
The mean values for the relative weight content of C16:1ω7, C18:1ω9 or C20:1ω9 did not 
differ significantly from one another in the four groups of rats under consideration (Table 
24). No C22:1ω9 could be detected in any of the 16 samples of visceral adipose tissue. 
 
Rats C16:1ω7 C18:1ω9 C20:1ω9 
Control before 39.95 ± 3.73 328.06 ± 7.87 1.83 ± 0.10 
 after (8 wk) 40.90 ± 3.13 341.94 ± 3.67 1.77 ± 0.05 
ω3D before 38.02 ± 7.35 321.17 ± 9.80 1.75 ± 0.16 
 after (8 wk) 40.07 ± 3.25 342.42 ± 13.01 1.68 ± 0.03 
Table 24. Relative weight content (‰) of monodesaturated fatty acids in visceral adipose 
tissue lipids 
3.8 Food intake and body weight 
As indicated in Table 25, over the last 7-8 weeks of the present experiments, both the food 
intake and relative gain in body weight were higher (p < 0.05 or less) in the ω3D rats 
maintained on the sunflower oil diet than in either the control rats maintained on the soya 
oil diet or the ω3D rats switched to the latter diet. It could be objected that the relative 
magnitude of the changes in body weight exceeded that of the changes in food intake. 
However, taking into account the differences in both body weight gain and food intake, the 
estimated caloric efficiency was close to the expected theoretical value, as documented by 
the following considerations. In one group of 4 ω3D rats maintained for a further period of 7 
weeks on the sunflower diet, the daily food intake (19.61 ± 0.27 g/day per rat; n = 30) 
exceeded by 1.93 ± 0.51 g/day per rat (p < 0.001) that recorded in one group of 4 control 
animals maintained on the soya oil diet (17.68 ± 0.43 g/day per rat; n = 30). In these two 
groups of rats, the gain in body weight over the same period of 7 weeks averaged 1.93 ± 0.14 
g/day per rat in the ω3D rats as distinct (p < 0.02) from 1.09 ± 0.11 g/day per rat in the 
control animals. The caloric requirement to account for the difference in body weight gain (≤ 
7.6 ± 1.6 cal) was thus commensurate with the increase in the caloric supply of the diet (6.2 ± 
1.6 cal), which provided about 3.2 cal/g. 
 
Rats Food intakea Relative gain in body weightb 
Control soya oil diet 100.0 ± 1.6 (31) 13.35 ± 1.38 (4) 
ω3D sunflower oil diet 112.1 ± 2.5 (56) 24.67 ± 1.82 (2) 
ω3D soya oil diet 104.4 ± 1.6 (45) 12.97 ± 2.70 (4) 
aThe food intake over the last 8 weeks of the present experiments is expressed relative to the mean value 
found at the same time after the initial 3 months period in control animals maintained on the soya oil diet 
bThe relative gain in body weight (%) was assessed by comparison of individual measurements made at 
the end of the initial 3 months period and seven weeks thereafter 
Table 25. Food intake and relative gain in body weight 
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3.9 HOMA index for insulin resistance 
At the end of the 3 months initial period, the logarithmic values of the HOMA index for 
insulin resistance were higher (df = 4; p < 0.02) in the ω3D rats than in the control animals. 
In the former ω3D rats, such values progressively decreased after the switch in diet as a 
function of the length of exposure to the soya oil diet (r = - 0.5956; n = 12; p < 0.05). Eight 
weeks after the switch in diet, the HOMA index eventually reached in the ω3D rats a mean 
value (1.16 ± 0.09 U/l.mM; n = 3) comparable (p > 0.7) to that found at the same time in the 
control animals also exposed to the soya oil diet (1.20 ± 0.05 U/l.mM; n = 3). 
4. Discussion 
The present experimental design prevents any undesirable aggravation of liver steatosis and 
visceral obesity, as well as food intake, otherwise resulting from an increase in the lipid 
content of the diet from 5 to 10% (Malaisse et al., 2009; Sener et al., 2009). It also caused 
correction of insulin resistance in the ω3D rats. 
The exposure of ω3D to the soya oil diet also allowed the repletion of long-chain 
polyunsaturated ω3 fatty acids in the intestinal tract, liver, red blood cell and brain 
phospholipids. 
The changes in the fatty acid pattern of tissue lipids were not always merely and directly 
attributable to the respective content of each diet in a given fatty acid, as documented by the 
accumulation of selected long-chain polyunsaturated ω6 fatty acids in the phospholipids of 
ω3D rats and the correction of this situation after the switch from the sunflower oil to soya 
oil diet. Incidentally, before such a switch the total amount of four ω3 fatty acids (C18:3ω3, 
C20:5ω3, C22:5ω3 and C22:6ω3) and three ω6 fatty acids (C20:4ω6, C22:4ω6 and C22:5ω6) 
was comparable in the control animals and ω3D rats (Carpentier et al., 2011b). 
The present findings also support the view that a transfer of information takes place between 
the liver and either RBC or brain, as documented for instance by the delayed alignment of the 
phospholipid fatty acid pattern in the latter two sites on that prevailing at the hepatic level. It 
was recently proposed that such a process may even be operative in the absence of any dietary 
deprivation of long-chain polyunsaturated ω3 fatty acids (Malaisse et al., 2010). 
Last, the present findings provide further evidence to the fact that changes in the dietary 
supply of ω3 fatty acids may also affect the relative content of tissue lipids in selected 
saturated and monodesaturated fatty acids. 
In conclusion, the procedure used in the present experiments appears indeed suitable to 
ensure the repletion of long-chain polyunsaturated ω3 fatty acids in previously ω3-depleted 
rats. 
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